Condition: Major Depressive Disorder (MDD) · Depression - Major Depressive Disorder · Sponsor: Gang Wang
This study aimed to evaluate the efficacy and safety of fecal microbiota transplantation (FMT) in patients with major depressive disorder (MDD) who exhibit suboptimal early response to antidepressant treatment. Additionally, it sought to investigate the impact of FMT on biological indicators, including intestinal microbiota and metabolites, in individuals with MDD
This description comes directly from the study's public registry record.
Gang Wang · 86 + 010-86430066
Always discuss trial participation with your own doctor first.
| Wuhu Fourth People's Hospital | Wuhu, Anhui, China | Recruiting |
| Beijing Anding Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Nangfang Hospital Affiliated of Southern Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| The First Affiliated Hospital of Hebei Medical University | Shijiazhuang, Hebei, China | Recruiting |
| Shandong Daizhuang Hospital | Jining, Shandong, China | Recruiting |
| West China Hospital Affiliated of Sichuan University | Chengdu, Sichuan, China | Recruiting |
| Tianjin Anding Hospital | Tianjin, Tianjin Municipality, China | Recruiting |
| The Second People's Hospital of Dali Bai Autonomous Prefecture | Dali, Yunnan, China | Recruiting |
| The First Affiliated Hospital of Zhejiang University | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06692361